Our Ideas - Chronic Illness

These are the posts from the Our Ideas section that have been tagged with Chronic Illness.

To see all tags used in our posts, click here.

Michael Seres - 11 Health - patient expert - Blue Latitude Health interview

Rise of the patient expert - an interview with Michael Seres

Liz Inskip | 22nd February 2017

Founded by Michael Seres in 2011, 11 Health is a connected medical device company currently working to change the lives of patients using stoma bags. Content Marketing Manager Liz Inskip interviews Michael about how patients are changing the role of the expert in healthcare, and the systematic barriers to innovation in healthcare.

read more

Blue Latitude Health - stock image - water cell circle

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Liz Inskip | 18th January 2017

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators in this therapy area are.

read more

patient-perspective-living-with-crohns-disease-blue-latitude-health

Living with Crohn's disease: a patient perspective

Victoria Morton | 16th November 2016

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for patients.

read more

Alzheimer's Disease eeviewing the immediate treatment horizon

Alzheimer’s disease: reviewing the immediate treatment horizon

Stuart Goodman | 2nd September 2016

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

read more

immunotherapy-in-oncology-innate-and-adaptive-immunity

Immunotherapy in oncology

David Cooney | 27th July 2016

In this article, Consultant David Cooney explores the medical insights, unmet needs, and future of the vastly growing area of immunotherapy as the fourth pillar in oncology.

read more

night-sky-space_Why-we-we-work_Blue-Latitude-Health

Why we work

Fred Bassett | 20th July 2016

A personal look at the drive and motivations behind our work at Blue Latitude Health from co-founder and Head of Strategy Fred Bassett.

read more

photographs-Alzheimers-the-numbers-we-cannot-forget

Alzheimer's: the numbers we cannot forget

David Cooney | 19th July 2016

In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.

read more

immunotherapy-perspective-magazine-blood-cells-Blue-Latitude-Health

The special immunotherapy edition of Perspective magazine is live

Blue Latitude Health | 19th May 2016

Blue Latitude Health have worked with four of the eight immunotherapies currently approved by the FDA, so we've pooled our expertise across the different capabilities to give you a clear view on the fourth pillar of care in oncology.

read more

clinic-medical-scientist-medicine-lab

Tackling biosimilars – how to handle the threat to pharma brands

Mark Assenti | 23rd September 2015

Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

read more

man-wearable-technology-belts-watches-trackers-overload

The ‘digital health revolution’ is here: What pharma needs to know

Simon Young | 24th June 2015

Director and Head of Commercial Simon takes us through some of the key themes of the Financial Times Digital Health Summit in London, outlining and expanding on where we feel the industry is heading as we get closer to the ‘digital health revolution’.

read more